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ABSTRACT 
         Rheumatoid arthritis (RA) is an autoimmune chronic disease that results in 
damage to tissues throughout the body due to the inability of the immune system 
in these patients to discriminate between self-tissues and foreign invaders. 
Currently available treatment strategies consist of immunosuppressive drugs, 
which are efficacious but are associated with side-effects, such as increased risk 
for infections. Re-establishment of the ability of the immune system to 
discriminate between self and non-self through the induction of self-tolerance is 
an attractive treatment strategy that might lead to a cure for RA. Another 
interesting treatment option for RA is the design of a disease-regulated therapy, 
which would only be activated during a flare of the disease. 
          The aims of this thesis are to: 1) investigate the induction of antigen-
specific tolerance in an animal model of RA (i.e., collagen induced arthritis; 
CIA); and 2) investigate whether disease-regulated production of an anti-
inflammatory cytokine can ameliorate CIA.  
          We used gene therapy to express collagen type II peptide (CII) on antigen-
presenting cells, so as to induce antigen-specific tolerance in animals with CIA. 
Our results show that gene therapy that targets haematopoietic stem cells induces 
strong resistance to the development of arthritis, and that B cells play a major 
role in the induction of tolerance. This effect is accompanied by increases in the 
suppressive capacities of T-regulatory cells and decreased levels of 
autoantibodies. We also show that gene therapy administered after immunisation 
with CII reduces the severity of CIA by decreasing the levels of autoantibodies 
and enhancing the suppression caused by T-regulatory cells.  
          Disease-regulated therapy was investigated using lentiviral-mediated 
transcription of IL-10 regulated by an IL-1 enhancer and IL-6 promoter. Our 
results show that gene therapy with an inflammation-dependent IL-10 gene 
construct generates increased levels of IL-10 in the lymph nodes, decreased 
levels of IL-6 in the serum, decreased levels of CII antibodies, and decreased 
severity of CIA. 
          In conclusion, we have developed gene therapy modalities and model 
systems that are well suited to investigations of the immunological mechanisms 
of antigen-specific tolerance and disease-regulated therapies in animal models of 
RA.  
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